Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa
- 1 October 1993
- journal article
- Published by Springer Nature in Human Genetics
- Vol. 92 (4) , 325-330
- https://doi.org/10.1007/bf01247328
Abstract
There is a high incidence of Niemann-Pick type B disease in the Maghreb region of North Africa, which includes Morocco, Algeria and Tunisia. A hypothesis that there may well be a common, predominant mutant acid sphingomyelinase allele responsible for the type B phenotype in this population has been tested. A deletion of an arginine codon at amino acid residue 608 was found in one patient. The same mutation was also observed in another of our cases. An original screening procedure using 3′end digoxigenin-labeled allele-specific oligonucleotides and chemiluminescent detection was developed and used parallel to the conventional assay with 5′-end radiolabeled oligonucleotides. Of the 15 non-related, non-Jewish North African type B patients studied, 12 were homozygous and two compound heterozygous for this deletion (26 ΔR608 alleles/30 mutant alleles). Among type B patients from other geographic regions (France, UK, Italy, Czechoslovakia), this mutation was observed in only one of the 16 alleles studied. Our results indicate that deletion of arginine 608 in the acid sphingomyelinase gene is the highly prevalent mutation underlying Niemann-Pick type B disease in the population of Maghreb. A varying severity of the clinical and enzymatic expression within the non-neuronopathic phenotype has however been observed in patients homozygous for the mutation.Keywords
This publication has 29 references indexed in Scilit:
- Molecular and Clinical Heterogeneity of Adult GM2 GangliosidosisDevelopmental Neuroscience, 1991
- Molecular basis of acid sphingomyelinase dificiency in a patient with Niemann-Pick disease type ABiochemical and Biophysical Research Communications, 1991
- Identification of an altered splice site in Ashkenazi Tay-Sachs diseaseNature, 1988
- A splicing defect due to an exon-intron junctional mutation results in abnormal β-hexosaminidase α chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs diseaseBiochemical and Biophysical Research Communications, 1988
- Different Mutations in Ashkenazi Jewish and Non-Jewish French Canadians with Tay-Sachs DiseaseScience, 1986
- A new variant of sphingomyelinase deficiency (Niemann‐Pick): visceromegaly, minimal neurological lesions and low in vivo degradation rate of sphingomyelinJournal of Inherited Metabolic Disease, 1985
- Biochemical studies in Niemann‐Pick disease. III: In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the diseaseClinical Genetics, 1985
- Niemann-Pick disease (variation in the sphingomyelinase deficient group)European Journal of Pediatrics, 1983
- Biochemical studies in niemann-pick disease I. Major sphingolipids of liver and spleenBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Metabolism of sphingomyelin by intact cultured fibroblasts: Differentiation of Niemann-Pick disease types A and BBiochemical and Biophysical Research Communications, 1982